Sarah Bos

132 CHAPTER 7 48. Potze W, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Hypercoagulability following major partial liver resection - detected by thrombomodulin-modified thrombin generation testing. Aliment Pharmacol Ther. 2015 Jan;41(2):189–98. 49. Tzeng C-WD, Katz MHG, Fleming JB, Pisters PWT, Lee JE, Abdalla EK, et al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB. 2012 Aug;14(8):506–13. 50. Stahl RL, DuncanA, HooksMA, HendersonMJ,MillikanWJ,WarrenWD. AHypercoagulable State Follows Orthotopic Liver Transplantation. Hepatology. 1990 Sep;12(3):553–8. 51. Reddy SK, Turley RS, Barbas AS, Steel JL, Tsung A, Marsh JW, et al. Post-Operative Pharmacologic Thromboprophylaxis after Major Hepatectomy. J Gastrointest Surg. 2011;15(9):1602–10. 52. Annamalai A, KimI, SundaramV, KleinA. Incidence and risk factors of deep vein thrombosis after liver transplantation. Vol. 46, Transplantation Proceedings. 2014. p. 3564–9. 53. Yip J, Bruno DA, Burmeister C, Kazimi M, Yoshida A, Abouljoud MS, et al. Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention. Transplant direct. 2016;2(4):e68. 54. Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, et al. Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy. J Gastrointest Surg. 2014 Jun 13;18(6):1116–24. 55. Bos S, Bernal W, Porte RJ, Lisman T. Hemostatic Complications in Hepatobiliary Surgery. Semin Thromb Hemost. 2017;43(7):732–41. 56. Lisman T, Porte RJ. Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management. Anesthesiology. 2017;126(2):338–44. 57. Duffy JP, Hong JC, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, et al. Vascular Complications of Orthotopic Liver Transplantation: Experience in More than 4,200 Patients. J Am Coll Surg. 2009;208(5):896–903. 58. Weiss MJ, Kim Y, Ejaz A, Spolverato G, Haut ER, Hirose K, et al. Venous thromboembolic prophylaxis after a hepatic resection: Patterns of care among liver surgeons. Vol. 16, Hpb. 2014. p. 892–8. 59. Yoshiya S, Shirabe K, Nakagawara H, Soejima Y, Yoshizumi T, Ikegami T, et al. Portal vein thrombosis after hepatectomy. World J Surg. 2014;38(6):1491–7. 60. Groeneveld DJ, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy. Br J Surg. 2016;103(6):735–43. 61. Pereboom ITA, Adelmeijer J, Van Leeuwen Y, Hendriks HGD, Porte RJ, Lisman T. Development of a severe von willebrand factor/adamts13 dysbalance during orthotopic liver transplantation. Am J Transplant. 2009;9(5):1189–96. 62. Kröll D, Nett PC, Borbély YM, Schädelin S, Bertaggia Calderara D, Alberio L, et al. The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study. Surg Obes Relat Dis [Internet]. 2018;14(12):1890–6. Available from: https://doi.org/10.1016/j. soard.2018.08.025 63. Mallett S V., Sugavanam A, Krzanicki DA, Patel S, Broomhead RH, Davidson BR, et al. Alter- ations in coagulation following major liver resection. Anaesthesia. 2016 Jun;71(6):657–68.